Maternal nutrient restriction (MNR) is a widespread cause of fetal growth restriction (FGR), an independent predictor of heart disease and cardiovascular mortality. Our objective was to examine the developmental and long-term impact of MNR-induced FGR on cardiac structure in a model that closely mimics human development.
A reduction in total caloric intake spanning pregestation through to lactation in guinea pig sows was used to induce FGR. Proliferation, differentiation, and apoptosis of cardiomyocytes were assessed in late-gestation fetal, neonatal, and adult guinea pig hearts. Proteomic analysis and pathway enrichment were performed on fetal hearts.
Cardiomyocyte proliferation and the number of mononucleated cells were enhanced in the MNR–FGR fetal and neonatal heart, suggesting a delay in cardiomyocyte differentiation. In fetal hearts of MNR–FGR animals, apoptosis was markedly elevated and the total number of cardiomyocytes reduced, the latter remaining so throughout neonatal and into adult life. A reduction in total cardiomyocyte number in adult MNR–FGR hearts was accompanied by exaggerated hypertrophy and a disorganized architecture. Pathway analysis identified genes related to cell proliferation, differentiation, and survival.
FGR influences cardiomyocyte development during critical windows of development, leading to a permanent deficiency in cardiomyocyte number and compensatory hypertrophy in a rodent model that recapitulates human development.
Access optionsAccess options
Subscribe to Journal
Get full journal access for 1 year
only $64.85 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Barker, D. J. & Osmond, C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1, 1077–1081 (1986).
Barker, D. J., Osmond, C., Golding, J., Kuh, D. & Wadsworth, M. E. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. Br. Med. J. 298, 564–567 (1989).
Barker, D. J., Winter, P. D., Osmond, C., Margetts, B. & Simmonds, S. J. Weight in infancy and death from ischaemic heart disease. Lancet 2, 577–580 (1989).
Burton, G. J., Fowden, A. L. & Thornburg, K. L. Placental origins of chronic disease. Physiol. Rev. 96, 1509–1565 (2016).
Jiang, B., Godfrey, K. M., Martyn, C. N. & Gale, C. R. Birth weight and cardiac structure in children. Pediatrics 117, e257–e261 (2006).
Barker, D. J. et al. The early origins of chronic heart failure: impaired placental growth and initiation of insulin resistance in childhood. Eur. J. Heart Fail 12, 819–825 (2010).
Eriksson, J. G., Kajantie, E., Lampl, M. & Osmond, C. Trajectories of body mass index amongst children who develop type 2 diabetes as adults. J. Intern. Med. 278, 219–226 (2015).
Ravelli, G. P., Stein, Z. A. & Susser, M. W. Obesity in young men after famine exposure in utero and early infancy. N. Engl. J. Med. 295, 349–353 (1976).
Stansfield, B. K. et al. Nonlinear relationship between birthweight and visceral fat in adolescents. J. Pediatr. 175, 1550–1559 (2016).
Paradis, A. N., Gay, M. S. & Zhang, L. Binucleation of cardiomyocytes: the transition from a proliferative to a terminally differentiated state. Drug Discov. Today 19, 602–609 (2014).
Zak, R. Cell proliferation during cardiac growth. Am. J. Cardiol. 31, 211–219 (1973).
Botting, K. J. et al. Early origins of heart disease: low birth weight and determinants of cardiomyocyte endowment. Clin. Exp. Pharmacol. Physiol. 39, 814–823 (2012).
Burrell, J. H. et al. Growth and maturation of cardiac myocytes in fetal sheep in the second half of gestation. Anat. Rec. A Discov. Mol. Cell Evol. Biol. 274, 952–961 (2003).
Botting K. J., McMillen I. C., Forbes H., Nyengaard J. R., Morrison J. L. Chronic hypoxemia in late gestation decreases cardiomyocyte number but does not change expression of hypoxia-responsive genes. J. Am. Heart Assoc. 3 (2014) e000531.
Louey, S., Jonker, S. S., Giraud, G. D. & Thornburg, K. L. Placental insufficiency decreases cell cycle activity and terminal maturation in fetal sheep cardiomyocytes. J. Physiol. 580, 639–648 (2007).
Morrison, J. L. et al. Restriction of placental function alters heart development in the sheep fetus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293, R306–R313 (2007).
Engle, W. A. & Lemons, J. A. Composition of the fetal and maternal guinea pig throughout gestation. Pediatr. Res. 20, 1156–1160 (1986).
Carter, A. M. Current topic: restriction of placental and fetal growth in the guinea-pig. Placenta 14, 125–135 (1993).
Ashwell, M., Purkins, L., Cowen, T. & Day, K. C. Pre- and postnatal development of adipose tissue at four sites in the guinea pig: effect of maternal diet restriction during the second half of pregnancy. Ann. Nutr. Metab. 31, 197–210 (1987).
Kind, K. L. et al. Chronic maternal feed restriction impairs growth but increases adiposity of the fetal guinea pig. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288, R119–R126 (2005).
Sohlstrom, A. et al. Food restriction alters pregnancy-associated changes in IGF and IGFBP in the guinea pig. Am. J. Physiol. 274, E410–E416 (1998).
Kind, K. L. et al. Restricted fetal growth and the response to dietary cholesterol in the guinea pig. Am. J. Physiol. 277, R1675–R1682 (1999).
Elias, A. A., Ghaly, A., Matushewski, B., Regnault, T. R. & Richardson, B. S. Maternal nutrient restriction in guinea pigs as an animal model for inducing fetal growth restriction. Reprod. Sci. 23, 219–227 (2016).
Nevin C. L., et al. Maternal nutrient restriction in guinea pigs as an animal model for studying growth restricted offspring with post-natal catch-up growth. Am. J. Physiol. Regul. Integr. Comp. Physiol. 219–27 (2018).
Soonpaa, M. H. & Field, L. J. Assessment of cardiomyocyte DNA synthesis during hypertrophy in adult mice. Am. J. Physiol. 266, H1439–H1445 (1994).
Bubb, K. J. et al. Intrauterine growth restriction delays cardiomyocyte maturation and alters coronary artery function in the fetal sheep. J. Physiol. 578, 871–881 (2007).
Briscoe, T. A. et al. Cardiovascular and renal disease in the adolescent guinea pig after chronic placental insufficiency. Am. J. Obstet. Gynecol. 191, 847–855 (2004).
Rolph, T. P., Jones, C. T. & Parry, D. Ultrastructural and enzymatic development of fetal guinea pig heart. Am. J. Physiol. 243, H87–H93 (1982).
Kind, K. L., Simonetta, G., Clifton, P. M., Robinson, J. S. & Owens, J. A. Effect of maternal feed restriction on blood pressure in the adult guinea pig. Exp. Physiol. 87, 469–477 (2002).
Porrello, E. R. et al. Transient regenerative potential of the neonatal mouse heart. Science 331, 1078–1080 (2011).
Levkau, B. et al. Survivin determines cardiac function by controlling total cardiomyocyte number. Circulation 117, 1583–1593 (2008).
Kooij, V. et al. Profilin modulates sarcomeric organization and mediates cardiomyocyte hypertrophy. Cardiovasc Res. 110, 238–248 (2016).
Crispi, F. et al. Fetal growth restriction results in remodeled and less efficient hearts in children. Circulation 121, 2427–2436 (2010).
Fernandez, E., Siddiquee, Z. & Shohet, R. V. Apoptosis and proliferation in the neonatal murine heart. Dev. Dyn. 221, 302–310 (2001).
Olivetti, G., Melissari, M., Capasso, J. M. & Anversa, P. Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ. Res. 68, 1560–1568 (1991).
Xu, Y., Williams, S. J., O’Brien, D. & Davidge, S. T. Hypoxia or nutrient restriction during pregnancy in rats leads to progressive cardiac remodeling and impairs postischemic recovery in adult male offspring. FASEB J. 20, 1251–1253 (2006).
Chen, X. et al. Adolescent feline heart contains a population of small, proliferative ventricular myocytes with immature physiological properties. Circ. Res. 100, 536–544 (2007).
Graham, E. & Bergmann, O. Dating the heart: exploring cardiomyocyte renewal in humans. Physiology 32, 33–41 (2017).
Weinberger, F. et al. Cardiac repair in guinea pigs with human engineered heart tissue from induced pluripotent stem cells. Sci. Transl. Med. 8, 363ra148 (2016).
Chen, J. X. et al. Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5. Circ. Res. 111, 50–55 (2012).
Ieda, M. et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142, 375–386 (2010).
Zhao, Y. et al. High-efficiency reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signalling. Nat. Commun. 6, 8243 (2015).
This work was supported by grants from the American Heart Association (B.K.S.); Department of Defense (B.K.S.); Department of Pediatrics, Augusta University, Augusta, GA (E.P.M., A.A.S., and B.K.S.); National Institutes of Health (J.A.T.); and the Children’s Health Research Institute, University of Western Ontario, London, Canada (TRHR, BSR). BSR is the recipient of a Canada Research Chair Tier I in Fetal and Neonatal Health and Development.
The authors declare no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Frontiers in Endocrinology (2019)
Cardiovascular Programming During and After Diabetic Pregnancy: Role of Placental Dysfunction and IUGR
Frontiers in Endocrinology (2019)
Early Human Development (2019)